Advertisement

Topics

Advent International Corporation Company Profile

11:19 EDT 22nd June 2018 | BioPortfolio

Advent is one of the leading private equity investors in North America. Since 1985, we have invested more than $1.5bn in over 275 companies across the US and Canada and have helped over 75 of these companies achieve successful IPOs. We pursue buyouts, recapitalizations and growth equity investments in selected growth industries. Target sectors include: Buyout/Private Equity – business and financial services, retail and consumer, IT services and technology, healthcare services, and industrial Our North American team comprises over 25 investment professionals working from regional headquarters in Boston. Our managing directors and partners have an average of over 10 years' investment experience

Location

75 State Street
Boston
Massachusetts
02109
United States of America

Contact

Phone: 1 617 951 9400
Fax: 1 617 951 0566


News Articles [262 Associated News Articles listed on BioPortfolio]

Sanofi to sell Zentiva generics arm to Advent

French drugmaker Sanofi announced on 17 April 2018 that it had entered into exclusive negotiations with Advent International (Advent) under which Advent would acquire Zentiva, Sanofi’s European gene...

Sanofi sells European generics business

Advent International and Sanofi have entered into exclusive negotiations under which Advent would acquire Zentiva, Sanofi's European generics business for €1,9 billion. Advent's offer is firm, bindi...

Advent In Talks To Buy Sanofi's European Generics Unit Zentiva For EUR 1.9 Bln

PARIS (dpa-AFX) - Advent International entered into exclusive negotiations to acquire Zentiva, Sanofi's (SNYNF, SNY) European generics business, for 1.9 billion euros. Advent's offer is firm, bind...

Advent in talks to buy Sanofi’s generics business for €1.9bn

French pharmaceutical giant Sanofi has entered into exclusive negotiations with US-based private equity firm Advent International to divest its European...Read More... The post Advent in talks to buy ...

Sanofi to Sell its Generic Division to Advent for $2.4 Billion

Sanofi has agreed to sell its generics division, Zentiva, to Advent International. The deal is expected to wrap by the end of this year.

Advent in talks to buy Sanofi’s European generics business for EUR1.9bn

US-based global private equity firm Advent International has entered into exclusive talks to acquire Sanofi’s European generics business, Zentiva, for €1.9bn.

Advent International closes in on deal for Sanofi’s generics unit

Health and diagnostics to soon be digitalized with advent of AI

Despite the fact that health in general globally is facing several challenges including antibiotic resistance, lack of accessible and affordable health care, rise of chronic and untreatable diseases s...

PubMed Articles [633 Associated PubMed Articles listed on BioPortfolio]

Optical Coherence Tomography Angiography Offers New Insights into Choriocapillaris Perfusion.

The choriocapillaris (CC) represents a fundamentally important vascular layer that is subject to physiologic changes with increasing age and that is also associated with a wide range of chorioretinal ...

Toward individual glomerular phenotyping: advent of precision medicine in kidney biopsies.

The road to precision medicine for nephrology is approaching quickly. In the present volume, the glomerular proteome has now been characterized at a single glomerulus level in mouse and human kidneys....

How to improve long-term outcome after liver transplantation?

The outcome of liver transplantation has markedly improved in the last 3 decades. Although early post-transplantation outcomes have improved over time, this is not true of the long-term outcome. The m...

Characteristics and outcomes of laparoscopic surgery in patients with large hiatal hernia. A single center study.

Giant hiatal hernia is characterized by the presence of more than 1/3 of the stomach in the chest, through the diaphragmatic hiatus, with or without other intra-abdominal organs. It is a rare patholog...

Management of HCV-Related Liver Disease in Hemophilia and Thalassemia.

Chronic infection with the hepatitis C virus (HCV) has long been the dominant complication of substitution therapy in patients with inherited blood disorders and the cause of anticipated death due to ...

Clinical Trials [1022 Associated Clinical Trials listed on BioPortfolio]

Advent™ Cervical Disc Versus Anterior Cervical Discectomy and Fusion(ACDF) for Treatment of One Level Degenerative Disc Disease (IDE Study)

The purpose of this study is to establish the safety and effectiveness of the Advent™ Cervical Disc compared to Anterior Cervical Discectomy and Fusion (ACDF) in treating degenerative di...

International AGD Database; Determinants of AGD and Establishment of Normative Data

Aim: To collate data on Anogenital Distance (AGD) from several population studies to build an international database for Anogenital Distance (AGD) Primary objective: To build a database p...

International Study on NoSocomial Pneumonia in Intensive CaRE

The International study on NoSocomial Pneumonia in Intensive CaRE (PneumoINSPIRE) is a prospective, international, multicentre, observational, cohort study. The study aims to provide up-to...

Cohort of STEMI Patients

Ischemic heart disease is the leading cause of mortality in industrialized countries. ST elevated acute myocardial infarction is one of its most frequent and deadly manifestation. In the l...

Effectiveness Study of the International Child Development Program

The objective of this study is to evaluate the effect of the International Child Development Program (ICDP). Research questions to be answered: 1. Does the ICDP affect children's psycho...

Companies [1450 Associated Companies listed on BioPortfolio]

Advent Consumer Healthcare, LLC

Advent Consumer Healthcare, LLC is dedicated to delivering innovative consumer products to help physicians and healthcare providers increase a patient’s overall awareness, in...

Advent Venture Partners

Advent Venture Partners is one of the most experienced technology venture capital firms in the UK. Established in 1981 it invests in both the Information and Communications Technology and Life Science...

Advent International Corporation

Advent is one of the leading private equity investors in North America. Since 1985, we have invested more than $1.5bn in over 275 companies across the US and Canada and have helped over 75 of these co...

Service Corporation International

Service Corporation International (NYSE: SCI), headquartered in Houston, Texas, is North America’s leading provider of deathcare products and services. At June 30, 2010, we o...

SPORTFIVE Int. Ltd.

Established in 2001, SPORTFIVE has quickly become the benchmark in sports rights marketing. Major shareholders include the private equity company Advent International, the media conglomerate RTL Group...

More Information about "Advent International Corporation" on BioPortfolio

We have published hundreds of Advent International Corporation news stories on BioPortfolio along with dozens of Advent International Corporation Clinical Trials and PubMed Articles about Advent International Corporation for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Advent International Corporation Companies in our database. You can also find out about relevant Advent International Corporation Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Healthcare
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...


Corporate Database Quicklinks



Searches Linking to this Company Record